References
Ambrosino P, Lupoli R, Di Minno A et al (2015) Subclinical atherosclerosis in patients with rheumatoid arthritis. A meta-analysis of literature studies. Thromb Haemost 113:916–930
Di Minno MN, Ambrosino P, Lupoli R et al (2015) Cardiovascular risk markers in patients with psoriatic arthritis: a meta-analysis of literature studies. Ann Med 47:346–353
Giollo A, Dalbeni A, Cioffi G et al (2017) Factors associated with accelerated subclinical atherosclerosis in patients with spondyloarthritis without overt cardiovascular disease. Clin Rheumatol. https://doi.org/10.1007/s10067-017-3786-3
Agca R, Heslinga SC, Rollefstad S et al (2017) EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Ann Rheum Dis 76:17–28
Bartoloni E, Shoenfeld Y, Gerli R (2011) Inflammatory and autoimmune mechanisms in the induction of atherosclerotic damage in systemic rheumatic diseases: two faces of the same coin. Arthritis Care Res 63:178–183
Bartoloni E, Alunno A, Gerli R (2017) Hypertension as a cardiovascular risk factor in autoimmune rheumatic diseases. Nat Rev Cardiol. https://doi.org/10.1038/nrcardio.2017.118
Feig DI, Kang D-H, Johnson RJ (2008) Uric acid and cardiovascular risk. N Engl J Med 359:1811–1821
Schretlen DJ, Inscore AB, Vannorsdall TD et al (2007) Serum uric acid and brain ischemia in normal elderly adults. Neurology 69:1418–1423
Niskanen LK, Laaksonen DE, Nyyssönen K et al (2004) Uric acid level as a risk factor for cardiovascular and all-cause mortality in middle-aged men: a prospective cohort study. Arch Intern Med 164:1546–1555
Zoppini G, Targher G, Negri C et al (2009) Elevated serum uric acid concentrations independently predict cardiovascular mortality in type 2 diabetic patients. Diabetes Care 32:1716–1720
Jalal DI, Chonchol M, Chen W et al (2013) Uric acid as a target of therapy in CKD. Am J Kidney Dis 61:134–146
Mantovani A, Rigolon R, Pichiri I et al (2016) Hyperuricemia is associated with an increased prevalence of atrial fibrillation in hospitalized patients with type 2 diabetes. J Endocrinol Investig 39:159–167
Paul BJ, Anoopkumar K, Krishnan V (2017) Asymptomatic hyperuricemia: is it time to intervene? Clin Rheumatol. https://doi.org/10.1007/s10067-017-3851-y
Panoulas VF, Milionis HJ, Douglas KM et al (2007) Association of serum uric acid with cardiovascular disease in rheumatoid arthritis. Rheumatology (Oxford) 46:1466–1470
Panoulas VF, Douglas KM, Milionis HJ et al (2008) Serum uric acid is independently associated with hypertension in patients with rheumatoid arthritis. J Hum Hypertens 22:177–182
Meek IL, Vonkeman HE, van de Laar MA (2014) Hyperuricaemia: a marker of increased cardiovascular risk in rheumatic patients: analysis of the ACT-CVD cohort. BMC Musculoskelet Disord 15:174
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
None.
Rights and permissions
About this article
Cite this article
Mantovani, A., Caimmi, C. & Orsolini, G. Cardiovascular morbidity and mortality in patients with rheumatic disease: hyperuricemia, a forgotten puzzle piece?. Clin Rheumatol 36, 2869–2870 (2017). https://doi.org/10.1007/s10067-017-3881-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-017-3881-5